(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO FARMACÊUTICO ADICIONAL

ArquivadaInvention PatentPCT · EP2004012877

Application data

Number

PI0416588

Type

Invention Patent

Filing

11/12/2004

Publication

01/30/2007

PCT

EP2004012877

Progress at the INPI

  1. Filing11/12/04
  2. Publication01/30/07
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 11/12/2004 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 04/28/2009. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

Novartis AG

CH

See this company's full portfolio

Inventors

F. P. (pessoa física)

FR

S. S. (pessoa física)

US

W. D. (pessoa física)

US

Technical data

Priority claims

US

60/519.965 · 11/14/2003

Abstract

"USO FARMACÊUTICO ADICIONAL". A presente invenção refere-se a um composto (S)-N-(1-carbóxi-2-metilprop-1-il)-N-pentanoil-N-[2 (1H-tetrazol-5-il)bifenil-4-ilmetil]amina (valsartan) de fórmula (I) ou um sal do mesmo, em particular um sal farmaceuticamente aceitável do mesmo, pode ser usado para tratar a síndrome nefrótica.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

04/28/2009

RPI 1999

Arquivamento - Art. 33 da LPI

#11.1

09/02/2008

RPI 1965

Notificação de entrada na fase nacional - PCT

#1.3

01/30/2007

RPI 1882

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.